Celecoxib and Electrocardiogram st segment abnormal - a phase IV clinical study of FDA data

Summary:

Electrocardiogram st segment abnormal is found among people who take Celecoxib, especially for people who are female, 10-19 old, have been taking the drug for 6 - 12 months.

The phase IV clinical study analyzes which people take Celecoxib and have Electrocardiogram st segment abnormal. It is created by eHealthMe based on reports of 30,460 people who have side effects when taking Celecoxib from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 14, 2023

30,460 people reported to have side effects when taking Celecoxib.
Among them, 11 people (0.04%) have Electrocardiogram st segment abnormal.

What is Celecoxib?

Celecoxib has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 30,651 Celecoxib users for its effectiveness, alternative drugs and more.

What is Electrocardiogram st segment abnormal?

Electrocardiogram st segment abnormal is found to be associated with 1,011 drugs and 428 conditions by eHealthMe.

Number of Celecoxib and Electrocardiogram st segment abnormal reports submitted per year:

Could Celecoxib cause Electrocardiogram st segment abnormal?

Time on Celecoxib when people have Electrocardiogram st segment abnormal *:

Gender of people who have Electrocardiogram st segment abnormal when taking Celecoxib *:

female: 75 %
male: 25 %

Age of people who have Electrocardiogram st segment abnormal when taking Celecoxib *:

Common drugs people take besides Celecoxib *:

Diclofenac: 9 people, 81.82%
Euthyrox: 9 people, 81.82%
Paracetamol: 8 people, 72.73%
Vitamin D: 5 people, 45.45%
Zocor: 1 person, 9.09%
Hydroxychloroquine Sulfate: 1 person, 9.09%
Aspirin: 1 person, 9.09%
Clarinex: 1 person, 9.09%
Felodipine: 1 person, 9.09%
Glipizide: 1 person, 9.09%

Common side effects people have besides Electrocardiogram st segment abnormal *:

White Blood Cell Count Decreased: 9 people, 81.82%
Influenza Like Illness: 9 people, 81.82%
Increased Tendency To Bruise (increased tendency to injure the underlying soft tissue or bone): 9 people, 81.82%
Impaired Gastric Emptying: 9 people, 81.82%
Ileus Paralytic (obstruction of the intestine due to paralysis of the intestinal muscles): 9 people, 81.82%
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood): 9 people, 81.82%
Vena Cava Thrombosis (clotting of the blood in large vein carrying deoxygenated blood into the heart): 9 people, 81.82%
Haematemesis (vomiting of blood): 9 people, 81.82%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 9 people, 81.82%
Fatigue (feeling of tiredness): 9 people, 81.82%

Common conditions people have *:

Glioma (a type of tumour that starts in the brain or spine): 8 people, 72.73%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 6 people, 54.55%
Oedema (fluid collection in tissue): 6 people, 54.55%
Muscle Spasms (muscle contraction): 6 people, 54.55%
Muscle Aches (muscle pain): 6 people, 54.55%
Abdominal Pain Upper: 6 people, 54.55%
Thrombosis (formation of a blood clot inside a blood vessel): 5 people, 45.45%
Thyroiditis (inflammation of thyroid gland): 2 people, 18.18%
Haemorrhage (bleeding): 2 people, 18.18%
Thyroiditis Chronic (long lasting inflammation of thyroid gland): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Celecoxib and have Electrocardiogram st segment abnormal?

Check whether Electrocardiogram st segment abnormal is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Electrocardiogram st segment abnormal and when was it recovered:

Electrocardiogram st segment abnormal in Celecoxib

Expand to all the drugs that have ingredients of celecoxib:

Electrocardiogram st segment abnormal and drugs with ingredients of celecoxib

Alternative drugs to, pros and cons of Celecoxib:

Celecoxib (30,651 reports)

Common Celecoxib side effects:

Drug ineffective: 4,459 reports
Pain: 2,192 reports
Joint pain: 1,971 reports
Fatigue (feeling of tiredness): 1,664 reports
Diarrhea: 1,600 reports
Rashes (redness): 1,580 reports
Rheumatoid arthritis (a chronic progressive disease causing inflammation in the joints): 1,494 reports

Browse all side effects of Celecoxib:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Electrocardiogram st segment abnormal treatments and more:

Electrocardiogram st segment abnormal (1,484 reports)

COVID vaccines that are related to Electrocardiogram st segment abnormal:

Common drugs associated with Electrocardiogram st segment abnormal:

Aspirin: 107 reports

All the drugs that are associated with Electrocardiogram st segment abnormal:

Electrocardiogram st segment abnormal (1,011 drugs)

All the conditions that are associated with Electrocardiogram st segment abnormal:

Electrocardiogram st segment abnormal (428 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celecoxib) and Celecoxib (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.